ROXRO PHARMA Gets $42.7M
Menlo Park-based ROXRO PHARMA, a pharmaceuticals firm developing pain treatments, said today that it has raised $42.7M in a second financing round. The round was led by Prospect Venture Partners and Sutter Hill Ventures; Thomas Weisel Healthcare Venture Partners also participated. ROXCO recently completed Phase 3 clinical trials of its leading compound, a intranasal pain reliever.
posted on Tuesday, June 12, 2007 (Link to more information)
Related companies:
Roxro Pharma
Related stories:
> Circle Pharma Ups Funding To $6.5M
> Zosano Pharma Raises $45M
> Zosano Pharma Expected To IPO Next Week
> BridgeBio Pharma Adds $125M
> Gemmus Pharma Gets Series A
silicontap.com Home